{"DataElement":{"publicId":"5981320","version":"1","preferredName":"Invasive Breast Carcinoma Glandular Acinar Tubular Differentiation Nottingham Histologic Score Outcome","preferredDefinition":"Results of the Nottingham histologic score for the percentage of glandular/tubular structuresÂ in a breast specimen.","longName":"IBC_GATD_NOTSC_OUTCM","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"5981239","version":"1","preferredName":"Invasive Breast Carcinoma Glandular Acinar Tubular Differentiation","preferredDefinition":"A carcinoma that infiltrates the breast parenchyma.  The vast majority are adenocarcinomas arising from the terminal ductal lobular unit (TDLU).  Often, the invasive adenocarcinoma co-exists with ductal or lobular carcinoma in situ.  It is the most common carcinoma affecting women._A morphologic finding indicating the presence of acinar and tubular differentiation  in a tissue sample of an epithelial neoplasm.","longName":"2431278v1.0:5981237v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"2431278","version":"1","preferredName":"Invasive Breast Carcinoma","preferredDefinition":"A carcinoma that infiltrates the breast parenchyma.  The vast majority are adenocarcinomas arising from the terminal ductal lobular unit (TDLU).  Often, the invasive adenocarcinoma co-exists with ductal or lobular carcinoma in situ.  It is the most common carcinoma affecting women. --2003","longName":"C9245","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Invasive Breast Carcinoma","conceptCode":"C9245","definition":"A carcinoma that infiltrates the breast parenchyma.  The vast majority are adenocarcinomas arising from the terminal ductal lobular unit (TDLU).  Often, the invasive adenocarcinoma co-exists with ductal or lobular carcinoma in situ.  It is the most common carcinoma affecting women.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"05DCF1A1-FAC7-3A7D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-18","endDate":null,"createdBy":"UMLLOADER_CAP","dateCreated":"2005-11-18","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"5981237","version":"1","preferredName":"Glandular (Acinar)/Tubular Differentiation","preferredDefinition":"A morphologic finding indicating the presence of acinar and tubular differentiation  in a tissue sample of an epithelial neoplasm.","longName":"C139289","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Glandular (Acinar)/Tubular Differentiation","conceptCode":"C139289","definition":"A morphologic finding indicating the presence of acinar and tubular differentiation  in a tissue sample of an epithelial neoplasm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"59784843-0109-06C1-E053-F662850A7F59","latestVersionIndicator":"Yes","beginDate":"2017-09-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-09-18","modifiedBy":"ONEDATA","dateModified":"2017-09-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NCI CRF Standards","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"59784843-011A-06C1-E053-F662850A7F59","latestVersionIndicator":"Yes","beginDate":"2017-09-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-09-18","modifiedBy":"HARTLEYG","dateModified":"2018-06-06","changeDescription":"9/18/17 tt New DEC, added CSI, per Round 5 finalization task.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5979388","version":"1","preferredName":"Nottingham Histologic Score Glandular Acinar Tubular Differentiation Outcome","preferredDefinition":"A numeric representation combining three histologic reporting elements, tubule formation, nuclear pleomorphism and mitotic count, to determine the grade of breast cancer.  The Nottingham Score is a factor in determining the Nottingham Prognostic Index._A morphologic finding indicating the presence of acinar and tubular differentiation  in a tissue sample of an epithelial neoplasm._The result of an action.","longName":"5979388v1.0","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"7","maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Score cannot be determined","valueDescription":"Score Indeterminate","ValueMeaning":{"publicId":"5979436","version":"1","preferredName":"Score Indeterminate","longName":"5979436","preferredDefinition":"A number or range of numeric values measuring performance, function, quality, or ability.: Cannot distinguish between two or more possible values in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Score","conceptCode":"C25338","definition":"A number or range of numeric values measuring performance, function, quality, or ability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Indeterminate","conceptCode":"C48658","definition":"Cannot distinguish between two or more possible values in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"592848D1-85A6-07D3-E053-F662850A6D47","latestVersionIndicator":"Yes","beginDate":"2017-09-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-09-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5929FC8D-0B9B-6C60-E053-F662850AAE0D","beginDate":"2017-09-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-09-14","modifiedBy":"ONEDATA","dateModified":"2017-09-14","deletedIndicator":"No"},{"value":"Only microinvasion present not graded","valueDescription":"Microinvasive Breast Carcinoma Present Negation Histologic Grade","ValueMeaning":{"publicId":"5979438","version":"1","preferredName":"Microinvasive Breast Carcinoma Present Negation Histologic Grade","longName":"5979438","preferredDefinition":"Ductal carcinoma in situ of the breast with minimal stromal invasion.  Lymph node involvement is uncommon and the prognosis is generally good.: Being or existing in a specified place or at the specified time.: An operation in which a term denies or inverts the meaning of another term or construction.: The degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. The degree of differentiation often relates to the clinical behavior of the particular tumor. Based on the microscopic findings, tumor grade is commonly described by one of four degrees of severity. Histopathologic grade of a tumor may be used to plan treatment and estimate the future course, outcome, and overall prognosis of disease. Certain types of cancers, such as soft tissue sarcoma, primary brain tumors, lymphomas, and breast have special grading systems.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Microinvasive Breast Carcinoma","conceptCode":"C40374","definition":"Invasive breast carcinoma measuring 1 mm or less in size.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Present","conceptCode":"C25626","definition":"Being or existing in a specified place or at the specified time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Histologic Grade","conceptCode":"C18000","definition":"The degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. The degree of differentiation often relates to the clinical behavior of the particular tumor. Based on the microscopic findings, tumor grade is commonly described by one of four degrees of severity. Histopathologic grade of a tumor may be used to plan treatment and estimate the future course, outcome, and overall prognosis of disease. Certain types of cancers, such as soft tissue sarcoma, primary brain tumors, lymphomas, and breast have special grading systems.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"592848D1-85F5-07D3-E053-F662850A6D47","latestVersionIndicator":"Yes","beginDate":"2017-09-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-09-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5929FC8D-0BA5-6C60-E053-F662850AAE0D","beginDate":"2017-09-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-09-14","modifiedBy":"ONEDATA","dateModified":"2017-09-14","deletedIndicator":"No"},{"value":"No residual invasive carcinoma","valueDescription":"Negation Residual Invasive Carcinoma","ValueMeaning":{"publicId":"5979437","version":"1","preferredName":"Negation Residual Invasive Carcinoma","longName":"5979437","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction.: Remaining or left behind.: A carcinoma that is not confined to the epithelium, and has spread to the surrounding stroma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Residual","conceptCode":"C37895","definition":"Remaining or left behind.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Invasive Carcinoma","conceptCode":"C9480","definition":"A carcinoma that is not confined to the epithelium, and has spread to the surrounding stroma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"592848D1-85CD-07D3-E053-F662850A6D47","latestVersionIndicator":"Yes","beginDate":"2017-09-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-09-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5929FC8D-0BAF-6C60-E053-F662850AAE0D","beginDate":"2017-09-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-09-14","modifiedBy":"ONEDATA","dateModified":"2017-09-14","deletedIndicator":"No"},{"value":"Score 3","valueDescription":"Glandular (Acinar)/Tubular Differentiation Score 3","ValueMeaning":{"publicId":"5979389","version":"1","preferredName":"Glandular (Acinar)/Tubular Differentiation Score 3","longName":"5979389","preferredDefinition":"Less than 10% of tumor area shows glandular/tubular structures.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Glandular (Acinar)/Tubular Differentiation Score 3","conceptCode":"C138977","definition":"Less than 10% of tumor area shows glandular/tubular structures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"59195B31-03D8-4DF3-E053-F662850A2508","latestVersionIndicator":"Yes","beginDate":"2017-09-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-09-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"59195B31-03F1-4DF3-E053-F662850A2508","beginDate":"2017-09-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-09-13","modifiedBy":"ONEDATA","dateModified":"2017-09-13","deletedIndicator":"No"},{"value":"Score 2","valueDescription":"Glandular (Acinar)/Tubular Differentiation Score 2","ValueMeaning":{"publicId":"5979390","version":"1","preferredName":"Glandular (Acinar)/Tubular Differentiation Score 2","longName":"5979390","preferredDefinition":"10% to 75% of tumor area shows glandular/tubular structures.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Glandular (Acinar)/Tubular Differentiation Score 2","conceptCode":"C138976","definition":"10% to 75% of tumor area shows glandular/tubular structures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"59195B31-03FB-4DF3-E053-F662850A2508","latestVersionIndicator":"Yes","beginDate":"2017-09-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-09-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"59195B31-0414-4DF3-E053-F662850A2508","beginDate":"2017-09-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-09-13","modifiedBy":"ONEDATA","dateModified":"2017-09-13","deletedIndicator":"No"},{"value":"Score 1","valueDescription":"Glandular (Acinar)/Tubular Differentiation Score 1","ValueMeaning":{"publicId":"5979391","version":"1","preferredName":"Glandular (Acinar)/Tubular Differentiation Score 1","longName":"5979391","preferredDefinition":"Greater than 75% of tumor area shows glandular/tubular structures.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Glandular (Acinar)/Tubular Differentiation Score 1","conceptCode":"C138975","definition":"Greater than 75% of tumor area shows glandular/tubular structures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"59195B31-041E-4DF3-E053-F662850A2508","latestVersionIndicator":"Yes","beginDate":"2017-09-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-09-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"59195B31-0437-4DF3-E053-F662850A2508","beginDate":"2017-09-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-09-13","modifiedBy":"ONEDATA","dateModified":"2017-09-13","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"5981236","version":"1","preferredName":"Nottingham Score Glandular (Acinar)/Tubular Differentiation Outcome","preferredDefinition":"A numeric representation combining three histologic reporting elements, tubule formation, nuclear pleomorphism and mitotic count, to determine the grade of breast cancer.  The Nottingham Score is a factor in determining the Nottingham Prognostic Index.:A morphologic finding indicating the presence of acinar and tubular differentiation  in a tissue sample of an epithelial neoplasm.:The result of an action.","longName":"C25595:C139289:C20200","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nottingham Score","conceptCode":"C25595","definition":"A numeric representation combining three histologic reporting elements, tubule formation, nuclear pleomorphism and mitotic count, to determine the grade of breast cancer. The Nottingham Score is a factor in determining the Nottingham Prognostic Index.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Glandular (Acinar)/Tubular Differentiation","conceptCode":"C139289","definition":"A morphologic finding indicating the presence of acinar and tubular differentiation  in a tissue sample of an epithelial neoplasm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"59774380-E754-3DC9-E053-F662850A82BD","latestVersionIndicator":"Yes","beginDate":"2017-09-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-09-18","modifiedBy":"ONEDATA","dateModified":"2017-09-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NCI CRF Standards","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"59195B31-03BF-4DF3-E053-F662850A2508","latestVersionIndicator":"Yes","beginDate":"2017-09-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-09-13","modifiedBy":"TAYLORT","dateModified":"2019-06-13","changeDescription":"9/19/17 tt New VD replaces 2432055 to incorporate 2017 CAP Nottingham Score guidelines.  9/13/17 tt Draft new VD, added CSI, per Round 5 finalization task.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5506112","version":"1","longName":"Breast","context":"MCL","ClassificationSchemeItems":[{"publicId":"6643181","version":"1","longName":"Initial Diagnosis","context":"MCL"}]},{"publicId":"5506116","version":"1","longName":"Pathology","context":"MCL","ClassificationSchemeItems":[{"publicId":"5855640","version":"1","longName":"Breast Pathology","context":"MCL"}]},{"publicId":"5635300","version":"1","longName":"Case Report Form (CRF) Modules","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"5915898","version":"1","longName":"Microscopic Pathology","context":"NCI Standards"}]},{"publicId":"7434158","version":"1","longName":"CTEP CDISC Harmonization","context":"CTEP","ClassificationSchemeItems":[{"publicId":"11422194","version":"1","longName":"CTEP CDISC Diagnosis Microscopic Pathology","context":"CTEP"}]}],"AlternateNames":[{"name":"CTEP","type":"USED_BY","context":"CTEP"},{"name":"MI_MIORRES_TBLFRM","type":"CTEP CDISC CDE","context":"CTEP"}],"ReferenceDocuments":[{"name":"Glandular tubular differentia","type":"Preferred Question Text","description":"Glandular tubular differentiation","url":null,"context":"NCI Standards"},{"name":"Round 5","type":"Alternate Question Text","description":"Glandular (acinar)/tubular differentiation","url":null,"context":"NCI Standards"},{"name":"College of American Pathologists Protocol for the Examination of Specimens From Patients With Invasive Carcinoma of the Breast","type":"REFERENCE","description":"Version: Invasive Breast 4.0.0.0; Protocol Posting Date: June 2017","url":"http://www.cap.org/","context":"NCI Standards"},{"name":"MCL-PCA -1","type":"Alternate Question Text","description":"Glandular (acinar)/tubular differentiation","url":null,"context":"NCI Standards"},{"name":"CTEP Text 1","type":"Alternate Question Text","description":"What is the Nottingham tubule formation score?","url":null,"context":"CTEP"},{"name":"CTEP Text 2","type":"Alternate Question Text","description":"Nottingham tubule formation score","url":null,"context":"CTEP"}],"origin":"NCI CRF Standards","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"597BFC69-0B6D-2680-E053-F662850AA414","latestVersionIndicator":"Yes","beginDate":"2017-09-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-09-18","modifiedBy":"CLOHNES","dateModified":"2022-10-13","changeDescription":"9/18/17 tt New CDE replaces 2431553 to incorporate 2017 CAP Nottingham Score guidelines; added CSI, per Round 5 finalization task.","administrativeNotes":"10/12/22 added alt name, 3 AQT, classification for CTEP CDISC Harmonization project cjl;","unresolvedIssues":null,"deletedIndicator":"No"}}